
Africa Leads New TB Vaccine Trial That Could Save Millions
Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century. The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.
%2Ffile%2Fattachments%2Forphans%2FDrThatoMtshaliSOCCO_543675.jpg)
%2Ffile%2Fattachments%2Forphans%2F2HIVVaccineResearch_437240.jpg)




%2Ffile%2Fattachments%2Forphans%2FLearners-engage-with-Radio-astronomer-and-astrophysicist-Dr-Sphesihle-Makhathini-on-light-based-technologies_676239.jpg)
